Please assess the completion status of the following clinical trial:

Trial Title: Immediate Parent -Infant Skin-to-Skin Study (IPISTOSS)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Born in gestation week plus days 28+0 - 32+6.~* Born at maternity ward at study center~* Consent from parents/caregivers~* Parent or caregiver or substitute are available to start skin-to-skin Contact during the first hour of life.~Exclusion Criteria:~* Born outside the hospital~* Triplets or more~* Known malformation which will require immediate surgical action~* On-going resuscitation or intensive Medical care (mechanic ventilation or inotropy) after the first lifespan~  \* Known congenital infection~* Parent/care giver can not communicate in Swedish/Norwegian or English~* Not suited for the study for other reasons (according to the principal investigator)

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Skin-to-skin Contact group (Type: EXPERIMENTAL): Neonates in gestational age between 28+0 - 32+6 will get continuous Skin-to-skin contact with one parent/caregiver the first 6 hours after birth and as much as possible the first 72 hours after birth.
- Conventional care group (Type: ACTIVE_COMPARATOR): Neonates in gestational age between 28+0 - 32+6 will get Conventional care - incubators, warmers etc - the first 72 hours after birth.

Based on this trial design, predict the completion outcome and termination type (if applicable).